Association of paraoxonase (PON)1 activity, glutathione S-transferase GST T1/M1 and STin.2 polymorphisms with comorbidity of tobacco use disorder and mood disorders

Neuroscience Letters

Volumn 585, Issue , 2015, Pages 132-137

  Vargas Nunes, Sandra Odebrecht ^a,d   Pizzo de Castro, Márcia Regina ^a   Moreira, Estefania Gastaldello ^a,d   Guembarovski, Roberta Losi ^a   Barbosa, Decio Sabbatini ^a,d   Vargas, Heber Odebrecht ^a   Piccoli de Melo, Luiz Gustavo ^a   Bortolasci, Chiara Cristina ^a   Watanabe, Maria Angelica Ehara ^a   Dodd, Seetal ^b,c   Berk, Michael ^b,c   Maes, Michael ^a,b,d  

^a STATE UNIVERSITY OF LONDRINA   (Brazil)

^b DEAKIN UNIVERSITY   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

Depression; Genetic; Mood disorders; Oxidative stress; Polymorphism; Serotonin; Tobacco use disorder

Indexed keywords

ARYLDIALKYLPHOSPHATASE 1; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; PSYCHOTROPIC AGENT; SECOND INTRON2 PROTEIN; SEROTONIN TRANSPORTER; UNCLASSIFIED DRUG; ARYLDIALKYLPHOSPHATASE; GLUTATHIONE S-TRANSFERASE M1; GLUTATHIONE S-TRANSFERASE T1; GLUTATHIONE TRANSFERASE; PON1 PROTEIN, HUMAN; SLC6A4 PROTEIN, HUMAN;

ADULT; AGED; ALLELE; ARTICLE; CASE CONTROL STUDY; COMORBIDITY; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOOD DISORDER; PSYCHOPHARMACOTHERAPY; TOBACCO DEPENDENCE; ADOLESCENT; GENETICS; METABOLISM; MIDDLE AGED; MOOD DISORDERS; TOBACCO USE DISORDER; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ARYLDIALKYLPHOSPHATASE; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; GENETIC ASSOCIATION STUDIES; GLUTATHIONE TRANSFERASE; HUMANS; MALE; MIDDLE AGED; MOOD DISORDERS; POLYMORPHISM, GENETIC; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS; TOBACCO USE DISORDER; YOUNG ADULT;

EID: 84914811342     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2014.11.002     Document Type: Article

References (28)

1. American Psychiatric Association Tobacco-Related Disorders of DSM-5 In Diagnostic and Statistical Manual of Mental Disorders 2013, vol 5:571-577. 5th ed.).
2. Abdel-Rahman S.Z., El-Zein R.A., Anwar W.A., Au W.W. A multiplex PCR procedure for polymorphic analysis of GSTM1 and GSTT1 genes in population studies. Cancer Lett. 1996, 107(2):229-233.
3. Aviran M., Rosenblat M. Paraoxonases 1, 2, and 3, oxidative stress, and macrophage foam cell formation during atherosclerosis development. Free Radical Biol. Med. 2004, 37(9):1304-1316.
4. Berk M., Williams L.J., Jacka F.N., O' Neil A., Pasco J.A., Moylan S., Allen N.B., Stuart A.L., Hayley A.C., Byrne M.L., Maes M. So depression is an inflamatory disease, but where the inflammation come from?. BMC Med. 2013, 11:200.
5. Bortolasci C.C., Vargas H.O., Souza-Nogueira A., Barbosa D.S., Moreira E.G., Nunes S.O.V., Berk M., Dodd S., Maes M. Lowered plasma paraoxonase (PON) 1 activity is a trait marker of major depression and PON1 Q192R gene polymorphism-smoking interactions differentially predict the odds of major depression and bipolar disorder. J. Affective Disorders 2014, 159:23-30.
6. Centers for Disease Control and Prevention (CDC) Quitting smoking among adults: United States, 2001-2010. Morbility Mortality Weekly Rep. 2011, 60(44):1513-1519.
7. Del Ben C.M., Vilela J.A.A., Crippa J.A.S., Hallak J.E.C., Labate C.M., Suadi A.W. Confiabilidade da entrevista clinica estruturada para o DSM-IV - versão clínica traduzida para o português. Rev. Bras. Psiquiatr. 2001, 23(3):156-159.
8. de Castro M.R.P., Maes M., Guembarovski R.L., Ariza C.B., Reiche E.M.V., Vargas H.O., Vargas M.M., de Melo L.G.P., Dodd S., Berk M., Watanabe M.A.E., Nunes S.O.V. SLC6A4 STin2 VNTR genetic polymorphism is associated with tobacco use disorder, but not with successful smoking cessation or smoking characteristics: a case control study. BMC Genet. 2014, 15:78.
9. Furlong C., Holland N., Richter R., Bradman A., Ho A., Eskenazi B. PON1 status of farmworker mothers and children as a predictor of organophosphate sensitivity. Pharmacogenet. Genomics 2006, 16:183-190.
10. Lasser K., Boyd J.W., Woolhandler S., Himmelstein D.U., McCormick D., Bor D.H. Smoking and mental illness: a population-based prevalence study. JAMA 2000, 284(20):2606-2610.
11. Maes M., Galecki P., Chang Y.S., Berk M. A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the neurodegenerative process in the illness. Prog. Neuropsychopharmacol. Biol. Psychiatry 2011, 35(3):676-692.
12. Maes M., Ringel K., Kubera M., Berk M., Rybakowski J. Increased autoimmune activity against 5-HT: a key component of depression that is associated with inflammation and activation of cell-mediated immunity, and with severity and staging of depression. J. Affective Disorders 2012, 136:386-392.
13. Maes M., Fišar Z., Medina M., Scapagnini G., Nowak G., Berk M. New drug targets in depression: inflammatory cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology 2012, 20(3):127-150.
14. Middleton E.T., Morice A.H. Breath carbon monoxide as an indication of smoking habit. Chest 2000, 117(3):758-763.
15. Mohammadynejad P., Saadat I., Ghanizadeh A., Saadat M. Bipolar disorder and polymorphisms of glutathione S-transferases M1 (GSTM1) and T1 (GSTT1). Psychiatry Res. 2011, 186(1):144-146.
16. Moreno R.A., Moreno D.H. Hamilton and Montgomery & Åsberg depression rating scales. Rev. Psiquiatr. Clin. 1998, 25:262-272.
17. Morris G.A.G., Dean O., Berk M., Galecki P., Martin-Subero M., Maes M. The glutathione system: a new drug target in neuro-immune disorders. Mol. Neurobiol. 2014, in press. 10.1007/s12035-014-8705-x.
18. Moylan S., Maes M., Wray N.R., Berk M. The neuroprogressive nature of major depressive disorder: pathways to disease evolution and resistance and therapeutic implications. Mol. Psychiatry 2012, 18(5):595-606.
19. Nunes S.O.V., Vargas H.O., Brum J., Prado E., Vargas M.M., de Castro M.R.P., Dodd S., Berk M. A comparison of inflammatory markers in depressed and non-depressed smokers. Nicotine Tob. Res. 2012, 14:540-546.
20. Nunes S.O.V., de Castro M.R.P., Vargas H.O., Vargas M.M., Bueno R.R.M., Fonseca I.C.B., Dodd S., Berk M. Clinical characteristics and smoking cessation: an analysis of sex and depressive disorders differences. Addict. Disorders Treat. 2013, 12(3):158-165.
21. Nunes S.O.V., Vargas H.O., Prado E., Barbosa D.S., Melo L.P., Moylan S., Dodd S., Berk M. The shared role of oxidative stress and inflammation in major depressive disorder and nicotine dependence. Neurosci. Biobehav. Rev. 2013, 37:1336-1345.
22. Nunes S.O.V., de Castro M.R.P., Watanabe M.A.E., Guembarovski R.L., Vargas H.O., Reiche E.M.V., Morimoto H.K., Dodd S., Berk M. Genetic polymorphisms in glutathione-S- transferases are associated with anxiety and mood disorders in nicotine dependence. Psychiatr. Genet. 2014, 24:87-93.
23. Sarosi A., Gonda X., Balogh G., Domotor E., Szekely A., Hejjas K., Sasvari-Szekely M., Faludi G. Association of the STin2 polymorphism of the serotonin transporter gene with a neurocognitive endophenotype in major depressive disorder. Prog. Neuropsychopharmacol. Biol. Psychiatry 2008, 32:1667-1672.
24. Sullivan P.F. Spurious genetic associations. Biol. Psychiatry 2007, 61(10):1121-1126.
25. Vargas H.O., Nunes S.O.V., de Castro M.R.P., Vargas M.M., Barbosa D.S., Bortolasci C.C., Venugopal K., Dodd S., Berk M. Oxidative stress and inflammatory markers are associated with depression and nicotine dependence. Neurosci. Lett. 2013, 544:136-140.
26. Vargas H.O., Nunes S.O.V., Vargas M.M., Barbosa D.S., Cestari A., Dodd S., Venugopal K., Maes M., Berk M. Castelli risk indexes 1 and 2 are higher in major depression but other characteristics of the metabolic syndrome are not specific to mood disorders. Life Sci. 2014, 102:65-71.
27. Tsuang M.T., Francis T., Minor K., Thomas A., Stone W.S. Genetics of smoking and depression. Hum. Genet. 2012, 131(6):905-915.
28. Zivkovic M., Stankovic A., Djuric T., Koncar I., Kolakovic A., Djurdjevic V., Davidovic L., Alavantic D. Effects of glutathione S-transferase T1 and M1 deletions on advanced carotid atherosclerosis, oxidative, lipid and inflammatory parameters. Mol. Biol. Rep. 2014, 41(2):1157-1164.